Gleevec

Patient groups put pressure on the company to move the drug along and now it turns out Gleevec is good for more than just one kind of cancer and may be helpful against many cancers.

Becker-Posner on Drug Patents, Arnold Kling | EconLog | Library of Economics and Liberty 2009

While considered fatal just five or six years ago, now there is a survival rate of 85-90 percent thanks to a pill called Gleevec, which is taken once a day.

NHL.com Feature Stories 2008

Glivec, known as Gleevec in the U.S., is Basel, Switzerland-based Novartis ' second-best selling drug after heart drug Diovan, generating close to $4 billion in sales last year.

U.K. Health Body Rejects Glivec for High Doses Goran Mijuk 2010

" The Emperor of All Maladies " gives short shrift to one of the most successful cancer treatments of the 20th century — bone-marrow transplants — which saved the lives of thousands of chronic myelogenous leukemia patients including this writer before a drug called Gleevec came along.

The Most Insidious Illness Laura Landro 2010

The other big object lesson in curing cancer comes from Gleevec, which is singlehandedly responsible for increasing the number of CML patients who survive at least eight years, from 20 percent in the past to 80 percent today.

Curing Cancer 2010

The drug, called Gleevec, allows patients to remain symptom-free for many years without a bone marrow transplant.

Basketball Legend Shoots, Walks for Cancer Cure 2010

Thailand's previous health minister, Mongkol na Songkhla, decided in early January to issue compulsory licenses (a policy that permits lower-cost generics) for four drugs: Novartis's imatinib, also known as Gleevec; Novartis's breast-cancer drug letrozole, whose brand name is Femara; Sanofi-Aventis's docetaxel, marketed as Taxotere and used to fight lung and breast cancer; and Roche's erlotinib, whose trade name is Tarceva.

Thai Ministry to Recommend 2008

The best example is a new drug called Gleevec [Glivec internationally], designed to treat patients with chronic myelogenous leukemia, or CML, one of the main types of blood cancer.

A Cure For Cancer? 2007

The agency approved Tasigna, an oral treatment for patients with a form of chronic myeloid leukemia, or CML, who've failed treatment with other drugs, including Gleevec, which is also made by Novartis.

FDA OKs Novartis Leukemia Drug 2007

For example, a gene-based medicine called Gleevec was approved last year for a type of leukemia after showing success where traditional cancer therapies had failed.

CNN Transcript Jan 2, 2002 2002